Last reviewed · How we verify

NCT05990270: EEWCCKAB

The Effect of Education Given to Women on Cervical Cancer on Knowledge, Attitude and Belief

Completed NA Last updated 24 June 2024
What this trial tests

NA trial testing education in Cancer of Cervix in 102 participants. Completed in 30 December 2023.

Timeline
15 August 2023
Primary endpoint
30 September 2023
30 December 2023

Quick facts

Lead sponsorKahramanmaras Sutcu Imam University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment102
Start date15 August 2023
Primary completion30 September 2023
Estimated completion30 December 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Kahramanmaras Sutcu Imam University

Who can join

Eligibility, female only, with Cancer of Cervix or HPV Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aim: The aim of this study is to reveal the effect of education given to women about cervical cancer on knowledge, attitude and belief. Material and Method: This randomized controlled study was conducted with 130 who had a public hospital located in Southeast Turkey (51 experimental, 51 control).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The Effect of Cervical Cancer Education Given to Women in Turkey on Knowledge, Attitudes, and Health Beliefs: A Randomized Controlled Study.
    Gül Öztaş H, Işik K. · · 2025 · cited 3× · PMID 39420668 · DOI 10.1111/phn.13456

Verify or expand the search:

Other trials of education

Trials testing the same drug.

Other recruiting trials for Cancer of Cervix

Currently open trials in the same condition.

Other Kahramanmaras Sutcu Imam University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05990270.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing